Patient satisfaction

Clarity Technologies Announces Significant Enhancements and Strategic Integrations to The Clarity Practice Performance System

Retrieved on: 
木曜日, 5月 9, 2024
Education, Clarity, EVO, Cataract, Software, Electronic health record, Intraocular lens, SMS, SVP, Patient, CRM, Patient satisfaction, Nursing

BOISE, Idaho, May 9, 2024 /PRNewswire/ -- Clarity Technologies, which recently revealed its rebrand following the merger of Engage Technologies Group and APX Platform, announces substantial new product features and strategic integrations for the Clarity Practice Performance System.

Key Points: 
  • BOISE, Idaho, May 9, 2024 /PRNewswire/ -- Clarity Technologies, which recently revealed its rebrand following the merger of Engage Technologies Group and APX Platform, announces substantial new product features and strategic integrations for the Clarity Practice Performance System.
  • The Clarity Practice Performance System is a first-of-its-kind healthcare practice software designed to give practice managers and owners a holistic way to optimize practice operations.
  • Finally, Clarity is announcing strategic integrations with robust EHRs like ModMed and Symplast, as well as the practice management software; Promptly.
  • Additionally, the integration with Symplast allows for seamless access to the Clarity Practice Performance System analytics module that provides structured data, industry benchmarks, and actionable insights for aesthetic practices.

YouScript Wins "Genomics Innovation Award" in 8th Annual MedTech Breakthrough Awards Program

Retrieved on: 
木曜日, 5月 9, 2024
Medtech, Health, Pharmacogenomics, Software, EHR, The, Electronic health record, Prescription, Patient safety, Telehealth, Medical device, Patient, Patient satisfaction, Medicine, Organization, Nursing

SEATTLE, May 9, 2024 /PRNewswire/ -- YouScript, an Aranscia company, today announced that it has been selected as winner of the "Genomics Innovation Award" in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market.

Key Points: 
  • SEATTLE, May 9, 2024 /PRNewswire/ -- YouScript , an Aranscia company, today announced that it has been selected as winner of the "Genomics Innovation Award" in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market.
  • YouScript's pharmacogenomics (PGx) software and solutions enable healthcare providers and organizations to build, deliver, and scale comprehensive personalized medication management programs.
  • Incorporating YouScript as part of a proactive personalized medication management program has been shown to help providers mitigate the potential for dangerous adverse drug events, including associated hospital and emergency department visits.
  • "We're honored to receive the 'Genomics Innovation Award' from MedTech Breakthrough and bring further awareness to our mission of helping providers improve patient safety and care," said Kristine Ashcraft, Founder and President, YouScript.

Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH

Retrieved on: 
火曜日, 5月 7, 2024
IMPACT, FDA, Teleflex, Urology, Prostate, PVP, PUL, LUTS, Heat, TFX, MD, TURP, Research, Mars, Prostatic urethral lift, Patient, Physician, Medicine, Urethra, AUA, ATC, Database, Patient satisfaction, Quality of life, BPH

“For over 10 years, Teleflex has advanced BPH research through numerous trials involving the UroLift™ system and now other contemporary treatments.

Key Points: 
  • “For over 10 years, Teleflex has advanced BPH research through numerous trials involving the UroLift™ system and now other contemporary treatments.
  • ***5
    Once procedure volume is factored in, the UroLift™ System has the lowest rates of mild, moderate, and severe postoperative complications on a per case basis from 2019 to 2022 in the MAUDE database.
  • The goal is for the provider and patient to decide whether to continue, stop, or switch to another therapy based on the symptomatic response of medication.
  • **9 It is the only leading enlarged prostate procedure that does not require heating, cutting, or destruction of prostate tissue.10-11
    For more information about the UroLift™ System, visit www.UroLift.com .

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

Retrieved on: 
月曜日, 5月 6, 2024
FDA, Bleeding, Safety, Risk, American Urological Association, Abstract, LUTS, ASC, Surgeon, TURP, International Prostate Symptom Score, Patient, SDD, AUA, Health, Patient satisfaction, Clinical trial, SAN, BPH, IPSS, Benign prostatic hyperplasia

The results were presented this past weekend at the American Urological Association (AUA) Annual Meeting in San Antonio, Texas.

Key Points: 
  • The results were presented this past weekend at the American Urological Association (AUA) Annual Meeting in San Antonio, Texas.
  • “The data presented at AUA confirm the safety and long-term durability of Aquablation therapy in treating men with symptomatic benign prostatic hyperplasia, regardless of prostate size or shape," said Reza Zadno, CEO of PROCEPT BioRobotics.
  • Three surgeons at Potomac Urology collected data on 812 consecutive men treated with Aquablation therapy.
  • We have treated more than 800 men with Aquablation therapy and feel that the results truly speak for themselves,” said Shawn Marhamati, MD, MS, at Potomac Urology.

VSS Capital Partners Portfolio Company Olympus Cosmetic Group Completes Acquisition of Artisan

Retrieved on: 
水曜日, 5月 8, 2024
Professional Services, Cosmetics, Retail, Health, Surgery, Other Health, Finance, Rheumatology, Eximia, VSS, Research, Practice management, McDermott Will & Emery, Surgeon, Partnership, Penn Mutual, Female, Patient, Acquisition, Physician, Day, Patient satisfaction, Growth, Medical device

VSS Capital Partners (“VSS”), a private investment firm investing in the healthcare, business services, and education industries, today announced that its portfolio company, Olympus Cosmetic Group (“Olympus”), a platform providing comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures, has completed the acquisition of Artisan Plastic Surgery and Artisan Beauté (collectively “Artisan” or the “Company”), a female-founded and managed cosmetic surgery and medspa enterprise.

Key Points: 
  • VSS Capital Partners (“VSS”), a private investment firm investing in the healthcare, business services, and education industries, today announced that its portfolio company, Olympus Cosmetic Group (“Olympus”), a platform providing comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures, has completed the acquisition of Artisan Plastic Surgery and Artisan Beauté (collectively “Artisan” or the “Company”), a female-founded and managed cosmetic surgery and medspa enterprise.
  • While financial terms of the transaction were not disclosed, VSS made an additional investment to support Olympus’ first acquisition.
  • “The team at Artisan is aligned seamlessly with Olympus Cosmetic Group’s mission to deliver quality and expertly performed cosmetic procedures to patients.
  • McDermott Will & Emery provided counsel to VSS and Olympus Cosmetic Group.

Access to Healthcare and Digital Tools Turning a Corner for the Better, According to Providers and Patients

Retrieved on: 
火曜日, 5月 7, 2024
Technology, Mobile, Wireless, Health, Other Health, Other Technology, Practice Management, Software, Managed Care, Networks, General Health, Hospitals, Health Technology, Health Insurance, Data Management, Multimedia, Environment, Patient satisfaction, Pulse, Insurance, Patient, Nursing

Healthcare providers and patients are in rare agreement that healthcare access and service-levels are improving, according to the Experian Health 2024 State of Patient Access survey.

Key Points: 
  • Healthcare providers and patients are in rare agreement that healthcare access and service-levels are improving, according to the Experian Health 2024 State of Patient Access survey.
  • View the full release here: https://www.businesswire.com/news/home/20240506665655/en/
    To access the free Experian Health State of Patient Access report, go to experian.com/state-patient-access.
  • Among patients who feel the patient access experience is better, they identified the following as improved:
    What is important to patients when evaluating healthcare access?
  • Despite a grim view of patient access in the 2022 survey, providers were optimistic they would turn the corner.

Independent Study Results in Japan Demonstrate Zero (0%) Breast Cancer Local Recurrence 5 Years Following Treatment with IceCure's ProSense®, Adding to Continued Positive Data Published Globally

Retrieved on: 
火曜日, 5月 7, 2024
Cryoablation, Cancer, Safety, Breast cancer, Woman, Freezing, Recurrence, Life, Patient, Neoplasm, Hospital, Patient satisfaction, ICE3, Quality of life, Medical imaging

The Study was led by Dr. Hisanori Kawamoto, M.D., Ph.D. from the Department of Breast Surgery, Breast and Imaging Center at St. Marianna University School of Medicine in Japan.

Key Points: 
  • The Study was led by Dr. Hisanori Kawamoto, M.D., Ph.D. from the Department of Breast Surgery, Breast and Imaging Center at St. Marianna University School of Medicine in Japan.
  • The authors of the Study refer to recent trials, including IceCure's ICE3 trial, for evidence that cryoablation results in local cancer control rates comparable to lumpectomies in early-stage breast cancer patients.
  • We are very pleased with these results and are hopeful that ProSense® may become a favored option in Japan upon regulatory approval for early-stage breast cancer."
  • Terumo Corporation owns the exclusive distribution rights for ProSense® in Japan for a 5-year term following regulatory approval.

Smart Meter Introduces World’s First Cellular-Enabled Glucose Meter with Notifications and Multi-Language Capabilities

Retrieved on: 
日曜日, 5月 5, 2024
Mobile, Wireless, Technology, Medical Devices, Diabetes, Health Technology, Telemedicine, Virtual Medicine, Other Health, Biometrics, Biotechnology, Health, RPM, Pharmacy, Smart, Smart meter, Life, Smartphone, Blood, Patient, LED, Physician, American Telemedicine Association, Multimedia, Patient satisfaction, Howard University, Telehealth, Medical device

iGlucose Plus is available with Spanish language on-screen prompts providing improved access to care to a largely underserved patient population.

Key Points: 
  • iGlucose Plus is available with Spanish language on-screen prompts providing improved access to care to a largely underserved patient population.
  • (Photo: Business Wire)
    The iGlucose Plus is an innovative glucose meter that is easy to use and requires no synching, pairing, smartphone, or Wi-Fi.
  • The new iGlucose Plus is an excellent example of that,” said Casey Pittock, CEO of Smart Meter.
  • The new iGlucose Plus will be on display at the American Telemedicine Association show in Phoenix, Arizona May 5 – 7 at Smart Meter’s booth #1007.

Pacific Islands Primary Care Association and HealthEfficient Partners with eClinicalWorks to Expand Community Access to Comprehensive Health Center Solutions

Retrieved on: 
木曜日, 5月 2, 2024
Technology, Hospitals, Health Technology, Software, Practice Management, Other Health, Managed Care, General Health, Health, Data Management, AI, Health information technology, Population health, EHR, Electronic health record, Partnership, Primary health care, Patient, HIT, UDS, Community, Patient satisfaction, Digital divide, HRSA, Nursing

The health centers are participants in the “Pacific Islands Electronic Health Initiative,” a federally funded project led by the Pacific Islands Primary Care Association (PIPCA) and its partner HealthEfficient , a not-for-profit organization based in New York.

Key Points: 
  • The health centers are participants in the “Pacific Islands Electronic Health Initiative,” a federally funded project led by the Pacific Islands Primary Care Association (PIPCA) and its partner HealthEfficient , a not-for-profit organization based in New York.
  • The Pacific Islands Primary Care Association promotes and supports quality primary health care throughout the Pacific Islands.
  • With our revolutionary technology, health centers have access to solutions that will enhance patient engagement, streamline documentation, and help increase access to care.”
    eClinicalWorks offers comprehensive health center solutions , including cloud solutions and integrations with primary care, dental, vision, value-based care, and behavioral health.
  • With access to eClinicalWorks integrated cloud-based solutions, PIPCA’s member health centers are better equipped to provide data-driven care to care to vulnerable populations.

Virtual Assistant Market Size to Grow USD 8613.5 Million by 2030 at a CAGR of 22.3% | Valuates Reports

Retrieved on: 
木曜日, 5月 2, 2024
USD, Fax, Retail, Growth, Automation, Health, Patient satisfaction, BFSI, Online shopping

The Global Virtual Assistant Market was valued at USD 2054.5 Million in 2023 and is anticipated to reach USD 8613.5 Million by 2030, witnessing a CAGR of 22.3% during the forecast period 2024-2030.

Key Points: 
  • The Global Virtual Assistant Market was valued at USD 2054.5 Million in 2023 and is anticipated to reach USD 8613.5 Million by 2030, witnessing a CAGR of 22.3% during the forecast period 2024-2030.
  • Major Factors Driving the Growth of Virtual Assistant Market:
    Because of its advanced digital infrastructure and early acceptance of technology, North America is the leader in the virtual assistant business.
  • This region's virtual assistant platform industry is growing due in part to the presence of large technological corporations and startups.
  • The growing requirement for efficient administrative support services is driving the virtual assistant market in the BFSI sector.